When working with KIT gene, a DNA segment that encodes the c‑KIT receptor tyrosine kinase. Also known as c‑KIT, it controls cell growth, survival, and differentiation in several tissues. The c‑KIT protein, the protein product of the KIT gene sits on the cell surface and needs tyrosine kinase activity, a signaling mechanism that adds phosphate groups to specific proteins to send messages inside the cell. When the gene mutates, the receptor can become stuck in the “on” position, driving unchecked cell division.
One major disease linked to abnormal KIT signaling is melanoma, a skin cancer that can harbor KIT mutations especially in mucosal and acral subtypes. In those cases, testing for KIT alterations guides targeted therapy decisions. Another well‑known condition is gastrointestinal stromal tumor (GIST), the most common mesenchymal tumor of the digestive tract, often driven by KIT mutations. For GIST patients, drugs that block the c‑KIT tyrosine kinase, like imatinib, have become standard of care. The shared thread is that the KIT gene influences both cancer risk and treatment response, making it a crucial biomarker in oncology.
Beyond cancer, the KIT gene also plays a role in normal processes such as pigment formation, blood cell development, and gut motility. Understanding how KIT variants affect these pathways helps clinicians anticipate side effects of KIT‑targeted drugs and monitor patients more effectively. Below you’ll find a curated list of articles that break down KIT‑related topics – from mutation testing methods and drug resistance mechanisms to real‑world case studies in melanoma and GIST. Dive in to see how this single gene shapes health and disease, and pick up practical tips you can apply whether you’re a patient, a caregiver, or a healthcare professional.
Explore whether excessive hair growth runs in families. Learn about the genetics behind hypertrichosis, key genes, inheritance patterns and testing options.